Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-18

FDA Approved: CLOZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Clozapine filed by Teva Pharmaceuticals USA, Inc. The approval indicates an update to the Clozapine product thro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clozapine (Clozapine)

Snippet

SUPPL AP for CLOZAPINE (CLOZAPINE)